India plans to maximise the auction of critical mineral blocks by 2031, advancing its strategic push to secure domestic ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system ...
Materion Corporation (NYSE: MTRN) today reported fourth quarter and full-year 2024 financial results, provided 2025 earnings guidance and announced a new mid-term profitability target. Fourth Quarter ...
Northisle is pleased to announce the results of the updated Preliminary Economic Assessment on the North Island Project.
Plus Therapeutics (PSTV) has closed a private placement with aggregate initial upfront proceeds of approximately $3.7 million and received a ...
Million Private Placement Financing from Existing Investors $2.0 Million Funding Advance from the Cancer Prevention and ...